
Zhiyao Technology uses artificial intelligence to accelerate discovery of small-molecule therapeutic candidates for preclinical development. The company combines AI models with medicinal chemistry, organic synthesis and biological activity evaluation to identify and optimize novel small molecules. It operates as a biotechnology R&D organization focused on preclinical drug discovery and collaborates with research teams and pharmaceutical partners. Zhiyao Technology targets the drug discovery market and aims to advance candidates toward clinical development.

Zhiyao Technology uses artificial intelligence to accelerate discovery of small-molecule therapeutic candidates for preclinical development. The company combines AI models with medicinal chemistry, organic synthesis and biological activity evaluation to identify and optimize novel small molecules. It operates as a biotechnology R&D organization focused on preclinical drug discovery and collaborates with research teams and pharmaceutical partners. Zhiyao Technology targets the drug discovery market and aims to advance candidates toward clinical development.